|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/50 |
| (11) | Patento numeris | 2588090 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11732405.3 |
| Europos patento paraiškos padavimo data | 2011-07-01 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-05-08 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-04-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2011/061140 |
| Data | 2011-07-01 |
| (87) | Numeris | WO 2012/001156 |
| Data | 2012-01-05 |
| (30) | Numeris | Data | Šalis |
| 201000209 | 2010-07-12 | SI | |
| 201000196 | 2010-07-01 | SI |
| (72) |
KROSELJ, Vesna, SI
JURSA KSELA, Sonja, SI
|
| (73) |
KRKA, tovarna zdravil, d.d., Novo mesto,
Smarjeska cesta 6, 8501 Novo mesto,
SI
|
| (54) | PHARMACEUTICAL ORAL DOSAGE FORMS COMPRISING DABIGATRAN ETEXILATE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS |
| PHARMACEUTICAL ORAL DOSAGE FORMS COMPRISING DABIGATRAN ETEXILATE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS |